Gene Expression Profiling in Human Ovarian Carcinoma Using Primary Tumorgrafts
These researchers have developed primary patient ovarian carcinoma tumorgrafts for the purpose of defining gene expression signatures linked to outcome and therapeutic response. A number of these models have been analyzed by DNA microarray. The next step is to analyze these arrays in conjunction with publicly available datasets via the appropriate Microarray Data Analysis Software (primary and ancillary). The number of arrays being analyzed simultaneously requires MSI's HPC hardware.